Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum Inhibition - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2023

Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum Inhibition

Résumé

The nucleotidase ISN1 is a potential therapeutic target of the purine salvage pathway of the malaria parasite Plasmodium falciparum. We identified PfISN1 ligands by in silico screening of a small library of nucleos(t)ide analogues and by thermal shift assays. Starting from a racemic cyclopentyl carbocyclic phosphonate scaffold, we explored the diversity on the nucleobase moiety and also proposed a convenient synthetic pathway to access the pure enantiomers of our initial hit (compound (±)-2). 2,6-Disubstituted purine containing derivatives such as compounds 1, (±)-7e and β-L-(þ)-2 showed the most potent inhibition of the parasite in vitro, with low micromolar IC 50 values. These results are remarkable considering the anionic nature of nucleotide analogues, which are known to lack activity in cell culture experiments due to their scarce capacity to cross cell membranes. For the first time, we report the antimalarial activity of a carbocyclic methylphosphonate nucleoside with an Llike configuration.
Fichier principal
Vignette du fichier
proof_EJMECH_115581 (1).pdf (1.71 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04269850 , version 1 (06-11-2023)

Identifiants

Citer

Bemba Sidi Mohamed, Minh Chau Nguyen, Sharon Wein, Jean-Pierre Uttaro, Xavier Robert, et al.. Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum Inhibition. European Journal of Medicinal Chemistry, 2023, 258, pp.115581. ⟨10.1016/j.ejmech.2023.115581⟩. ⟨hal-04269850⟩
5 Consultations
10 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More